of histamine H1-receptor antagonists on L-dopa-induced behavioral excitement were examined in mice to confirm behaviorally the inhibition of dopamine uptake by these compounds. L-Dopa (100-300 mg/kg, s.c.) combined with pargyline hydrochloride (80 mg/kg, i.p.) caused a dose-dependent behavioral excitement. The marked excitement induced by L-dopa (300 mg/kg) plus pargyline was significantly inhibited by pimozide (0.1-1 mg/kg, s.c.), a selective dopamine antagonist. Tripelennamine (10 mg/kg, s.c.), d-chlorpheniramine
ABSTRACT-Effects
of histamine H1-receptor antagonists on L-dopa-induced behavioral excitement were examined in mice to confirm behaviorally the inhibition of dopamine uptake by these compounds. L-Dopa (100-300 mg/kg, s.c.) combined with pargyline hydrochloride (80 mg/kg, i.p.) caused a dose-dependent behavioral excitement. The marked excitement induced by L-dopa (300 mg/kg) plus pargyline was significantly inhibited by pimozide (0.1-1 mg/kg, s.c.), a selective dopamine antagonist. Tripelennamine (10 mg/kg, s.c.), d-chlorpheniramine
(1 and 2 mg/kg, s.c.), homochlorcyclizine (2 and 5 mg/kg, s.c.), diphenhydramine (2 and 5 mg/kg, s.c.) and mepyramine (2 and 5 mg/kg, s.c.) each markedly enhanced the moderate behavioral excitement induced by L-dopa (150 mg/kg) plus pargyline. These findings are behavioral evidence for inhibition of dopamine uptake by H1 antagonists, which has been suggested by neurochemical studies.
Keywords:
Histamine H1-receptor antagonist, Dopamine uptake, L-Dopa Histamine H1-receptor antagonists have various ac tions in addition to H1-blocking action. Most H, an tagonists show antimuscarinic action, and some of these possess local anesthetic activity. In vitro experiments have shown that some H, antagonists inhibit the neuronal up take of dopamine, 5-hydroxytryptamine and noradrena line (1-3). We have examined the effects of H1 antago nists on monoamine turnovers in the mouse brain to evaluate the in vivo effects on monoamine uptake, and our data suggested that most H, antagonists inhibit the dopamine uptake to various degrees (4, 5). In this study, we tried to obtain behavioral evidence for inhibition of dopamine uptake by H, antagonists. For this purpose, we examined the effects of some H1 antagonists on the L dopa-induced behavioral excitement in mice.
Male ddY mice weighing 28 35 g (Seiwa Experimental Animals, Fukuoka) were used. For at least one week be fore the experiments, they were housed in a room con trolled at 22±2 C and lighted between 6:00 a.m. and 6:00 p.m. Food and water were given ad libitum. All experi ments were performed between 11:00 a.m. and 5:00 p.m.
All the animals were injected with pargyline hydro chloride (80 mg/kg, i.p.) 15 min before s.c. admin istration of L-dopa. To examine the effect of pimozide, it was injected simultaneously with L-dopa. To examine the effects of various H1 antagonists, they were injected i.p. immediately after L-dopa (150 mg/kg). Each of the animals was observed in an individual wire mesh cage (20 x 15 x 15 cm), and the degree of behavioral excite ment was scored as follows: 0, no behavioral excite ment; 1, piloerection or tail up; 2, moderate aggressive hypermotility; 3, marked aggressive hypermotility during almost all the observation period (5 min); 4, stereotyped sniffing or biting. Data were analyzed by the Kruskal Wallis test followed by the Mann-Whitney U-test.
Pargyline hydrochloride, tripelennamine hydrochlo ride and homochlorcyclizine dihydrochloride (Sigma Chemical Co., St. Louis, MO, USA); pimozide (Fujisawa Pharmaceutical Co., Osaka); d-chlorpheniramine male ate (Yoshitomi Pharmaceutical Co., Osaka); diphen hydramine hydrochloride (Tanabe Pharmaceutical Co., Osaka); and mepyramine maleate (ICN Pharmaceuticals, Plainview, NY, USA) were each dissolved in 0.9''o saline. L-Dopa (Nacalai Tesque, Kyoto) was suspended in 0.5% carboxymethyl cellulose. All drugs were administered in a volume of 0.1 ml per 10 g body weight. The dose of salt form drugs is expressed as weight of the salts.
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In the preliminary experiments, L-dopa (100-300 mg/kg, s.c.) plus pargyline caused a dose-dependent be havioral excitement. At 300 mg/kg, most animals showed maximum scores 90 and 120 min after treatment. As shown in Fig. 1 , pimozide, even at 0.1 mg/kg, i.p., sig nificantly inhibited the behavioral excitement induced by L-dopa (300 mg/kg) plus pargyline. The inhibitory effect was more marked at 0.3 and 1.0 mg/kg. In the mice treated with L-dopa (150 mg/kg) plus par gyline, the behavioral scores were about 1 from 15 to 90 min after treatment (Fig. 2) . However, in mice treated with tripelennamine simultaneously, the scores were mark edly higher and maximum in almost all animals 120 min after treatment. This potentiation was completely inhibit ed by pimozide (0.3 mg/kg). Figure 3 shows the scores of behavioral excitement 90 min after L-dopa (150 mg/kg) plus pargyline with or without the H1 antagonist. The scores were significantly increased by d-chlorpheniramine (1 and 2 mg/kg), diphenhydramine (2 and 5 mg/kg), homo chlorcyclizine (5 mg/kg) and mepyramine (5 mg/kg). Each H1 antagonist alone at any of the doses used had little influence on the behavior (data not shown). In the present study, we examined the effects of an H1 antagonist on L-dopa-induced behavioral excitement in mice to confirm behaviorally the inhibition of dopamine uptake by these compounds shown in neurochemical studies (2-5). L-Dopa (100-300 mg/kg) combined with pargyline caused a dose-dependent increase in behavioral excitement, in good agreement with the observation by Plotnikoff et al. (6). At 300 mg/kg, L-dopa caused a se vere excitement including stereotypy. This excitement was dose-dependently inhibited by pimozide, a selective do pamine receptor antagonist. Therefore, the L-dopa-in duced behavioral excitement observed in this study may be mainly mediated by activation of the dopaminergic system.
In in vitro studies, H1 antagonists such as diphen hydramine and chlorpheniramine have been reported to inhibit the neuronal uptake of dopamine (7). In this study, L-dopa-induced behavioral excitement was mark edly potentiated by tripelennamine and this potentiation was completely inhibited by pimozide, suggesting the involvement of the dopaminergic system. The L-dopa induced excitement was also potentiated by d-chlorphen iramine, diphenhydramine, homochlorcyclizine, and mepyramine which has no antimuscarinic activity (8). This is consistent with our previous suggestion that these H1 antagonists significantly inhibit dopamine uptake in vivo when evaluated as inhibition of dopamine turnover in the mouse brain (4, 5). The present findings together with the previous findings strongly suggest that various H1 antagonists enhance the function of the dopamin ergic system in the brain.
Suzuki et al. (9, 10) reported that the opioid con ditioned place preference is potentiated by H1 antagonists and abolished by dopamine D1-receptor antagonists. This phenomenon may be due to the inhibition of dopamine uptake by H1 antagonists. The enhancement of dopa minergic function by H1 antagonists may contribute to an addiction to H1 antagonists combined with opioids, such as "T's and blues", a combination of pentazocine and tripelennamine (11, 12). These effects may also partly contribute to their anti-parkinsonism activity. The inter action between H1 antagonists and dopamine related compounds should also be given attention.
